ASX:RAC

Race Oncology Limited (RAC.AX) Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range

A$0.34

MA: A$0.34▼

A$0.34

52-Week Range N/A

Volume76,322 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Race Oncology Limited operates as a specialty pharmaceutical company in Australia. It is developing Bisantrene, a small molecule cancer chemotherapy drug that is used for the treatment of acute myeloid leukaemia. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Melbourne, Australia.

Overall MarketRank^™

0.48 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Race Oncology Limited (RAC.AX).

2.4 Community Rank

Outperform Votes
Race Oncology Limited (RAC.AX) has received 19 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Race Oncology Limited (RAC.AX) has received 20 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Race Oncology Limited (RAC.AX) has received 51.28% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Race Oncology Limited (RAC.AX) and other stocks. Vote “Outperform” if you believe RAC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RAC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Race Oncology Limited (RAC.AX) does not currently pay a dividend.
Dividend Growth
Race Oncology Limited (RAC.AX) does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Race Oncology Limited (RAC.AX) insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange ASX

Industry Biotechnology

Sub-IndustryN/A

SectorMedical

Current SymbolASX:RAC

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.raceoncology.com

Phone61 3 9097 1656

EmployeesN/A

Debt

Debt-to-Equity RatioN/A

Current Ratio8.20

Quick Ratio7.30

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$159,371.00

Price / Sales0.00

Cash FlowN/A

Price / Cash Flow24.29

Book ValueA$0.05 per share

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

Receive RAC News and Ratings via Email

Sign-up to receive the latest news and ratings for RAC and its competitors with MarketBeat's FREE daily newsletter.

Race Oncology Limited (RAC.AX) (ASX:RAC) Frequently Asked Questions

What stocks does MarketBeat like better than Race Oncology Limited (RAC.AX)?

Wall Street analysts have given Race Oncology Limited (RAC.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Race Oncology Limited (RAC.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Race Oncology Limited (RAC.AX)'s earnings last quarter?

Race Oncology Limited (RAC.AX) (ASX:RAC) posted its earnings results on Wednesday, February, 27th. The company reported ($0.03) earnings per share for the quarter.
View Race Oncology Limited (RAC.AX)'s earnings history.

Who are some of Race Oncology Limited (RAC.AX)'s key competitors?

Some companies that are related to Race Oncology Limited (RAC.AX) include (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), 17031 (MYM), Abattis Bioceuticals (ATTBF), Abzena plc (ABZA.L) (ABZA), Acrux Limited (ACR.AX) (ACR), Actinogen Medical Limited (ACW.AX) (ACW), AdAlta Limited (1AD.AX) (1AD), ADiTx Therapeutics (ADTX), Admedus (AHZ), Alaric (HALB) and Algernon Pharmaceuticals (AGNPF).
View all of RAC's competitors.

What other stocks do shareholders of Race Oncology Limited (RAC.AX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Race Oncology Limited (RAC.AX) investors own include Mesoblast (MESO), Pilbara Minerals Limited (PLS.AX) (PLS) and Mount Gibson Iron Limited (MGX.AX) (MGX).

Who are Race Oncology Limited (RAC.AX)'s key executives?

Race Oncology Limited (RAC.AX)'s management team includes the following people:

Mr. Phillip R. Lynch, CEO, MD & Director
Dr. Daniel Tillett, Chief Scientific Officer & Exec. Director
Prof. Borje S. Andersson, Chairman of Clinical Advisory Board & Chief Medical Officer
Mr. Peter Gordon Webse M.A.I.C.D., B.Bus, FGIA, FCIS, FCPA, MAICD, Company Sec. (Age 58)

What is Race Oncology Limited (RAC.AX)'s stock symbol?

Race Oncology Limited (RAC.AX) trades on the ASX under the ticker symbol "RAC."

How big of a company is Race Oncology Limited (RAC.AX)?

Race Oncology Limited (RAC.AX) has a market capitalization of $0.00 and generates $159,371.00 in revenue each year.

What is Race Oncology Limited (RAC.AX)'s official website?

The official website for Race Oncology Limited (RAC.AX) is www.raceoncology.com.

How can I contact Race Oncology Limited (RAC.AX)?

The company can be reached via phone at 61 3 9097 1656.

This page was last updated on 1/17/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Race Oncology Limited (RAC.AX) Stock Forecast, Price & News

Adding

Adding

Adding Race Oncology Limited (RAC.AX)

MarketRank™

Overall MarketRank™